ESR1 and breast cancer: Furthermore, we verified a novel lncRNA, lnc-TRDMT1-5, which was not only upregulated in BC tissue samples and resistant cells but also related to poor prognosis in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2) -positive, and chemoresistant BC patients.